» Articles » PMID: 32123329

Disruptive and Avoidable: GDPR Challenges to Secondary Research Uses of Data

Overview
Journal Eur J Hum Genet
Specialty Genetics
Date 2020 Mar 4
PMID 32123329
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

The advent of the European Union's General Data Protection Regulation (GDPR) has posed several significant difficulties for the secondary research uses of data and associated biospecimens and has led to widespread unease within the international biobanking and databanking community. This disruption of research using personal data and associated biospecimens has gone largely unremarked in the professional literature, including in a recent account of GDPR's relationship to biobanking practices published in this journal, which instead advocated even more stringent, and in our view, unnecessary restrictions on research uses of banked data and materials. In this article, we describe challenges that GDPR has posed for biobanks and databanks and for researchers who use those banked resources for secondary research. We discuss the limitations inherent in the few pathways that GDPR makes available for secondary research, given that such pathways rely upon complex and varied laws of individual European Union member states. We advocate mitigation of these difficulties through regulatory guidance in order to allow important scientific research to continue.

Citing Articles

Challenges of sharing individual participant data for secondary research on neglected tropical diseases: the experience of Drugs for Neglected Diseases initiative and a call for action.

Tarwid J, Childs M, Junod-Moser D, Negrouk A, Egondi T, Tipple C BMJ Open. 2025; 14(12):e078862.

PMID: 39806656 PMC: 11667385. DOI: 10.1136/bmjopen-2023-078862.


Data protection legislation in Africa and pathways for enhancing compliance in big data health research.

Munung N, Staunton C, Mazibuko O, Wall P, Wonkam A Health Res Policy Syst. 2024; 22(1):145.

PMID: 39407232 PMC: 11479556. DOI: 10.1186/s12961-024-01230-7.


Artificial intelligence uncertainty quantification in radiotherapy applications - A scoping review.

Wahid K, Kaffey Z, Farris D, Humbert-Vidan L, Moreno A, Rasmussen M Radiother Oncol. 2024; 201:110542.

PMID: 39299574 PMC: 11648575. DOI: 10.1016/j.radonc.2024.110542.


EU-US data transfers: an enduring challenge for health research collaborations.

Lalova-Spinks T, Valcke P, Ioannidis J, Huys I NPJ Digit Med. 2024; 7(1):215.

PMID: 39152232 PMC: 11329736. DOI: 10.1038/s41746-024-01205-6.


Sharing sensitive data in life sciences: an overview of centralized and federated approaches.

Rujano M, Boiten J, Ohmann C, Canham S, Contrino S, David R Brief Bioinform. 2024; 25(4).

PMID: 38836701 PMC: 11151787. DOI: 10.1093/bib/bbae262.


References
1.
Staunton C, Slokenberga S, Mascalzoni D . The GDPR and the research exemption: considerations on the necessary safeguards for research biobanks. Eur J Hum Genet. 2019; 27(8):1159-1167. PMC: 6777499. DOI: 10.1038/s41431-019-0386-5. View